Quarterly report pursuant to Section 13 or 15(d)

COMMITMENTS (Details)

v3.24.1.u1
COMMITMENTS (Details)
3 Months Ended
Jan. 31, 2024
USD ($)
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Mar. 08, 2024
USD ($)
site
Feb. 01, 2024
Mar. 31, 2022
USD ($)
Long-term Purchase Commitment [Line Items]            
Operating lease, prior notice for cancellation 1 month          
Monthly rent expense $ 1,800          
Lease commenced, initial period         3 years  
Rent expense   $ 5,000 $ 4,000      
Research and development   2,428,000 $ 1,681,000      
Triple Ring Technologies            
Long-term Purchase Commitment [Line Items]            
Purchase commitments           $ 1,700,000
Remaining commitment   300,000        
Clinical Research Organization            
Long-term Purchase Commitment [Line Items]            
Remaining commitment   700,000        
Amount to be paid to Clinical Research Organization       $ 500,000    
Number of planned sites to carrying out the clinical study | site       5    
Research and development expense, expected cost   800,000        
Research and development   300,000        
Remaining commitment accrued   $ 200,000